Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic β cells

FASEB Journal

Volumn 21, Issue 12, 2007, Pages 3240-3249

  Glauser, Dominique A ^a   Schlegel, Werner ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Service de Néphrologie   (Switzerland)

Author keywords

c fos; Langerhans islets; Protein stability; Proteolysis

Indexed keywords

GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS; PROTEIN C JUN; PROTEIN FOS; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR AP 1; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; PANCREAS ISLET; PHYSIOLOGY; RAT; TUMOR CELL LINE; WISTAR RAT;

RATTUS;

ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 35148901638     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.06-7798com     Document Type: Article

References (44)

1. Weir, G. C., Laybutt, D. R., Kaneto, H., Bonner-Weir, S., and Sharma, A. (2001) Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes 50, S154-S159
2. Jonas, J. C., Sharma, A., Hasenkamp, W., Ilkova, H., Patane, G., Laybutt, R., Bonner-Weir, S., and Weir, G. C. (1999) Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J. Biol. Chem. 274, 14112-14121
3. Schuit, F., Flamez, D., De Vos, A., and Pipeleers, D. (2002) Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes 51, S326-S332
4. Hinke, S. A., Hellemans, K., and Schuit, F. C. (2004) Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal. J. Physiol. 558, 369-380
5. Webb, G. C., Akbar, M. S., Zhao, C., and Steiner, D. F. (2000) Expression profiling of pancreatic beta cells: glucose regulation of secretory and metabolic pathway genes. Proc. Natl. Acad. Sci. U. S. A. 97, 5773-5778
6. Jonas, J. C., Laybutt, D. R., Steil, G. M., Trivedi, N., Pertusa, J. G., Van de Casteele, M., Weir, G. C., and Henquin, J. C. (2001) High glucose stimulates early response gene c-Myc expression in rat pancreatic beta cells. J. Biol. Chem. 276, 35375-35381
7. Susini, S., Roche, E., Prentki, M., and Schlegel, W. (1998) Glucose and glucoincretin peptides synergize to induce c-fos, c-jun, junB, zif-268, and nur-77 gene expression in pancreatic beta(INS-1) cells. FASEB J. 12, 1173-1182
8. Jones, P. M., and Persaud, S. J. (1998) Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells. Endocr. Rev. 19, 429-461
9. Drucker, D. J. (2006) The biology of incretin hormones. Cell Metab. 3, 153-165
10. Thorens, B. (1995) Glucagon-like peptide-1 and control of insulin secretion. Diabete. Metab. 21, 311-318
11. Bernal-Mizrachi, E., Wen, W., Srinivasan, S., Klenk, A., Cohen, D., and Permutt, M. A. (2001) Activation of Elk-1, an Ets transcription factor, by glucose and EGF treatment of insulinoma cells. Am. J. Physiol. Endocrinol. Metab. 281, E1286-E1299
12. Susini, S., Van Haasteren, G., Li, S., Prentki, M., and Schlegel, W. (2000) Essentiality of intron control in the induction of c-fos by glucose and glucoincretin peptides in INS-1 beta-cells. FASEB J. 14, 128-136
13. Glauser, D. A., and Schlegel, W. (2006) Mechanisms of transcriptional regulation underlying temporal integration of signals. Nucleic Acids Res. 34, 5175-5183
14. Chen, R. H., Juo, P. C., Curran, T., and Blenis, J. (1996) Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene 12, 1493-1502
15. Abate, C., Patel, L., Rauscher, F. J., 3rd, and Curran, T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science 249, 1157-1161
16. Lilla, V., Webb, G., Rickenbach, K., Maturana, A., Steiner, D. F., Halban, P. A., and Irminger, J. C. (2003) Differential gene expression in well-regulated and dysregulated pancreatic beta-cell (MIN6) sublines. Endocrinology 144, 1368-1379
17. Greer, E. L., and Brunet, A. (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410-7425
18. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. (1988) Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J. 7, 4221-4229
19. Reffas, S., and Schlegel, W. (2000) Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Biochem. J. 352, 701-708
20. Burch, P. M., Yuan, Z., Loonen, A., and Heintz, N. H. (2004) An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry. Mol. Cell. Biol. 24, 4696-4709
21. Miyazaki, J., Araki, K., Yamato, E., Ikegami, H., Asano, T., Shibasaki, Y., Oka, Y., and Yamamura, K. (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127, 126-132
22. Acquaviva, C., Bossis, G., Ferrara, P., Brockly, F., Jariel-Encontre, I., and Piechaczyk, M. (2002) Multiple degradation pathways for Fos family proteins. Ann. N. Y. Acad. Sci. 973, 426-434
23. Coronella-Wood, J., Terrand, J., Sun, H., and Chen, Q. M. (2004) c-Fos phosphorylation induced by H2O2 prevents proteasomal degradation of c-Fos in cardiomyocytes. J. Biol. Chem. 279, 33567-33574
24. Okazaki, K., and Sagata, N. (1995) The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14, 5048-5059
25. Chen, R. H., Abate, C., and Blenis, J. (1993) Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc. Natl. Acad. Sci. U. S. A. 90, 10952-10956
26. Murphy, L. O., Smith, S., Chen, R. H., Fingar, D. C., and Blenis, J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564
27. Briaud, I., Lingohr, M. K., Dickson, L. M., Wrede, C. E., and Rhodes, C. J. (2003) Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes 52, 974-983
28. Gomez, E., Pritchard, C., and Herbert, T. P. (2002) cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagonlike peptide-1 in pancreatic beta-cells. J. Biol. Chem. 277, 48146-48151
29. Hodge, C., Liao, J., Stofega, M., Guan, K., Carter-Su, C., and Schwartz, J. (1998) Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 273, 31327-31336
30. Fujita, T., Ryser, S., Tortola, S., Piuz, I., and Schlegel, W. (2007) Gene-specific recruitment of positive and negative elongation factors during stimulated transcription of the MKP-1 gene in neuroendocrine cells. Nucleic Acids Res. 35, 1007-1017
31. Ryser, S., Fujita, T., Tortola, S., Piuz, I., and Schlegel, W. (2006) The rate of c-fos transcription in vivo is continously regulated at the level of elongation by dynamic stimulus-coupled recruitment of P-TEFb. J. Biol. Chem. 282, 5075-5084
32. Peng, S. S., Chen, C. Y., Xu, N., and Shyu, A. B. (1998) RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17, 3461-3470
33. Monje, P., Marinissen, M. J., and Gutkind, J. S. (2003) Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol. Cell Biol. 23, 7030-7043
34. Benes, C., Poitout, V., Marie, J. C., Martin-Perez, J., Roisin, M. P., and Fagard, R. (1999) Mode of regulation of the extracellular signal-regulated kinases in the pancreatic beta-cell line MIN6 and their implication in the regulation of insulin gene transcription. Biochem. J. 340, 219-225
35. Montrose-Rafizadeh, C., Avdonin, P., Garant, M. J., Rodgers, B. D., Kole, S., Yang, H., Levine, M. A., Schwindinger, W., and Bernier, M. (1999) Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology 140, 1132-1140
36. Arnette, D., Gibson, T. B., Lawrence, M. C., January, B., Khoo, S., McGlynn, K., Vanderbilt, C. A., and Cobb, M. H. (2003) Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J. Biol. Chem. 278, 32517-32525
37. Borge, P. D., Moibi, J., Greene, S. R., Trucco, M., Young, R. A., Gao, Z., and Wolf, B. A. (2002) Insulin receptor signaling and sarco/endoplasmic reticulum calcium ATPase in beta-cells. Diabetes. 51, S427-433
38. Lin, Y. W., Chuang, S. M., and Yang, J. L. (2003) ERK1/2 achieves sustained activation by stimulating MAPK phosphatase-1 degradation via the ubiquitin-proteasome pathway. J. Biol. Chem. 278, 21534-21541
39. Steinmetz, R., Wagoner, H. A., Zeng, P., Hammond, J. R., Hannon, T. S., Meyers, J. L., and Pescovitz, O. H. (2004) Mechanisms regulating the constitutive activation of the extracellular signal-regulated kinase (ERK) signaling pathway in ovarian cancer and the effect of ribonucleic acid interference for ERK1/2 on cancer cell proliferation. Mol. Endocrinol. 18, 2570-2582
40. Torres, C., Li, M., Walter, R., and Sierra, F. (2000) Modulation of the ERK pathway of signal transduction by cysteine proteinase inhibitors. J. Cell Biochem. 80, 11-23
41. Murphy, L. O., MacKeigan, J. P., and Blenis, J. (2004) A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol. Cell Biol. 24, 144-153
42. Yamamoto, T., Ebisuya, M., Ashida, F., Okamoto, K., Yonehara, S., and Nishida, E. (2006) Continuous ERK activation down-regulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 16, 1171-1182
43. Lingohr, M. K., Dickson, L. M., McCuaig, J. F., Hugl, S. R., Twardzik, D. R., and Rhodes, C. J. (2002) Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes 51, 966-976
44. Lawrence, M. C., McGlynn, K., Park, B. H., and Cobb, M. H. (2005) ERK1/2-dependent activation of transcription factors required for acute and chronic effects of glucose on the insulin gene promoter. J. Biol. Chem. 280, 26751-26759